David Backer

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.

Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA.

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

Part of Integra LifeSciences Holdings Corp., NeuroCare Group is a company that manufactures neurosurgical instruments and monitoring devices. The company is based in Carlsbad, CA. NeuroCare Group was acquired by Integra LifeSciences Holdings Corp. on March 29, 1999 for $14 million.

ParadigmHealth, Inc. provides disease management services. The company was founded in 1991 and is headquartered in Upper Saddle River, NJ.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Cour Pharmaceuticals Development Co., Inc. engages in the development of therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. Its product pipeline include celiac disease, peanut allergy, multiple sclerosis, and neutralizing antibodies. The company was founded by John J. Puisis and Jim Herrmann and is headquartered in Chicago, IL.

Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA.

Andelyn Biosciences is a full-service cell and gene therapy company that specializes in the development, characterization, and production of viral vectors for gene therapy. The private company is based in Columbus, OH. The company operates out of three facilities in Ohio and offers support to its clients in developing curative cell and gene therapies from concept through plasmid development and manufacturing, process development, and cgmp clinical and commercial manufacturing. Andelyn's advanced digital model, quality system, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of its clients' innovative cell and gene therapies. The company has more than 20 years of experience and has produced cgmp material for over 450 clinical batches and 75 clinical trials. Andelyn's versatile capabilities include cgmp manufacturing capacity for both adherent and suspension processes up to a 2,000-liter capacity. The CEO of the company is Wade Macedone.